Guardant Health partners with Nuvalent for cancer diagnostics development
Go back to Guardant Health partners with Nuvalent for cancer diagnostics development| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 155.87 +0.87 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $155.00 | 52 Week High | $5.84 | |||
| Open | $152.73 | 52 Week Low | $5.49 | |||
| Day High | $157.33 | P/E | N/A | |||
| Day Low | $149.78 | EPS | $0.00 | |||
| Volume | 1,997,111 | |||||
| Nuvel Holdings, Inc. (NASDAQ: NUVL) | Delayed: 123.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.96 | 52 Week High | $0.40 | |||
| Open | $123.96 | 52 Week Low | $0.14 | |||
| Day High | $123.96 | P/E | N/A | |||
| Day Low | $123.96 | EPS | $-0.56 | |||
| Volume | 68,411 | |||||
